Osteopathic Manipulation Makes a Neuropsychological Difference (BOD)

September 24, 2025 updated by: Mireille Rizkalla, Midwestern University

Examining Osteopathic Manipulation on Making a Neuropsychological Brain of Difference in Adults With Pain: A BOD Study Protocol and Rationale for a New Approach

Patients with pain commonly experience cognitive impairment. While symptoms of pain are effectively treated with osteopathic manipulative treatment (OMT), the cognitive piece is vastly ignored. Pain-induced cognitive dysfunction can be severe and is particularly apparent in working memory and attention. There is good reason to also expect cognitive responsiveness to OMT. Previous research has already reported related psychiatric outcomes, including relief from stress, self-perception and anxiety, suggesting that OMT may produce more global effects on cortical processing than currently thought.

Study Overview

Detailed Description

Patients with pain commonly experience cognitive impairment. While symptoms of pain are effectively treated with osteopathic manipulative treatment (OMT), the cognitive piece is vastly ignored. Previous research has already reported related psychiatric outcomes, including relief from stress, self-perception and anxiety, suggesting that OMT may produce more global effects on cortical processing than currently thought. The current study is designed to extend previous research in several ways:

  1. To describe the neuropsychological (NP) characteristics of adults with pain within an osteopathic and allopathic setting
  2. To correlate NP with clinical outcomes (pain severity, number/location of osteopathic lesions)
  3. To determine if OMT is associated with improved NP function.
  4. To use saliva to measure cytokine concentration of IL-1β,IL-6, IL-8, TNF-α
  5. To correlate cytokine concentrations with clinical outcomes (pain severity, number/location of osteopathic lesions, NP)

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Downers Grove, Illinois, United States, 60515
        • Midwestern Multispecialty Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. 40 years of age or older;
  2. seeking treatment for acute or chronic pain (neck, thoracic, shoulder, back)
  3. gives a positive response to the item, "Have you had thinking problems because of your pain?";
  4. agree to forego extra-trial manipulation (e.g., massage, chiropractic, physical therapy);
  5. Score > 23 on the Telephone Interview for Cognitive Status;
  6. written informed consent.

Exclusion Criteria:

  1. recent (< 2 month) or planned surgery within the duration of the study;
  2. use of medication that could interfere with cytokine measurements;
  3. recent (< 2 month) changes to psychotropic medication within the duration of the study;
  4. history of manipulation within the past six months.
  5. diagnosed neurocognitive disorders;
  6. contraindication to receiving OMT.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Osteopathic group
Treatment will be compromised of 8 weeks of standard care plus OMT. Each physician will maintain the same patient at recurring sessions. Osteopathic treatment is performed for 30 minutes and the techniques applied are highly individualized to the patient needs (i.e., techniques are selected based on structure/function, and techniques change over time based on treatment response). In an effort to standardize treatment, we will limit the study protocol to the following designated techniques: facilitated positional release treatment, high velocity low amplitude treatment, articulatory treatment, strain-counterstrain, muscle energy treatment, myofascial release treatment, soft tissue treatment.
Osteopathic manipulative treatment (OMT) is defined as the therapeutic application of manually guided forces by an osteopathic physician to improve physiologic function and/or support homeostasis that has been altered by somatic dysfunction. Somatic (body framework) dysfunction or altered function of related components is observed in the skeletal, arthrodial and myofascial structures, and their related vascular, lymphatic, and neural elements. Techniques can use a direct method where the restrictive barrier is engaged and a final activating force is applied to correct the somatic dysfunction, or an indirect method where the restrictive barrier is disengaged and the dysfunctional body part is moved away from the restrictive barrier until tissue tension is equal in one or all planes and directions
This group will refrain from getting OMT while in the study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
neuropsychology change
Time Frame: baseline, week 8, week 12
standardized assessment battery
baseline, week 8, week 12
pain scale change
Time Frame: baseline, week 8, week 12
1-10
baseline, week 8, week 12
inflammatory markers change
Time Frame: baseline, week 8, week 12
cortisol
baseline, week 8, week 12
inflammatory marker
Time Frame: baseline, week 8, week 12
TNF Alpha
baseline, week 8, week 12
Inflammatory marker
Time Frame: baseline, week 8, week 12
IL 6
baseline, week 8, week 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: mireille rizkalla, phd, Midwestern University
  • Study Director: Katrina Ivkovic, Midwestern University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2017

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2026

Study Registration Dates

First Submitted

April 6, 2017

First Submitted That Met QC Criteria

August 14, 2019

First Posted (Actual)

August 15, 2019

Study Record Updates

Last Update Posted (Estimated)

September 30, 2025

Last Update Submitted That Met QC Criteria

September 24, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Musculoskeletal Pain

Clinical Trials on Osteopathic Manipulative Treatment

Subscribe